Skip to main content
Log in

Cross-Linked β-Cyclodextrin Based Nanosponges for Allyl Methyl Sulfide Delivery-Physicochemical Characterization and In Vitro Study

  • Original Article
  • Published:
Journal of Pharmaceutical Innovation Aims and scope Submit manuscript

Abstract

Purpose

Our work aims to cross-linked cyclodextrin-based nanosponges for allyl methyl sulfide delivery, physicochemical characterization, and in vitro study.

Method

Plain nanosponges were created using the melting technique to react β-cyclodextrin with the cross-linker diphenyl carbonate at a molar ratio of 1:4, respectively. AFM, FESEM, GC–MS, PDI and zeta potential, PXRD, and FTIR were used to characterize the drug-loaded nanosponges. Additionally, compared to free allyl methyl sulfide, allyl methyl sulfide-nanosponges loaded nanosponges showed superior antioxidant and anti-inflammatory activities.

Result

The depth and surface characteristics of the particles were quantified using AFM. It was discovered that the nanosponge size was about 185 nm. The FESEM showed that the AMS-loaded formula had a very porous structure and a sponge-like shape. GCMS: The volatile components in the AMS were identified in the current experiment using GC–MS. With the largest percentage area among them, AMS was identified as a key component (19.753%). PDI and zeta: the AMS loaded NS at a 1:4 w/w ratio was chosen. The table below displays the AMS-typical NS particle size. For AMS-NS, the particle size distribution was likewise within the intended range. FTIR: C-H aliphatic structuring was found in the drug at 2977, 2915, and 2832. Similarly, C–C-structuring was found at 990,913,851. These peaks are also present in the drug-polymer matrix. PXRD: all strong peaks become muted after drug loading into the NS because of a transition to an amorphous state, indicating full drug entrapment. Antioxidant: AMS and AMS-NS were reduced when compared to the standard. This capacity is represented as the number of equivalents of ascorbic acid. Illustrates the DPPH inhibition effect of AMS and AMS-NS at different concentrations. It was observed that the DPPH inhibition effect of AMS was increased. Moreover, the loaded AMS-NS showed a higher reduction in the DPPH concentrations than the standard. Anti-inflammatory: AMS-NS reduced denaturation; the results were compared to the standard and significantly reduced.

Conclusion

The study demonstrated that the complexation of AMS with NS would be a workable strategy for formulation were much greater. Because of this, these investigations showed that nanosponges might be utilized to distribute AMS. Upcoming research on the beta-cyclodextrin nanosponges’ potential for in vivo medication delivery against cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Walag AMP, Ahmed O, Jeevanandam J, Akram M, Ephraim-Emmanuel BC, Egbuna C, et al. Health benefits of organosulfur compounds. Functional foods and nutraceuticals: bioactive components, formulations and innovations. 2020:445–72.

  2. Lawson L, Hunsaker S. Allicin bioavailability and bioequivalence from garlic supplements and garlic foods. Nutrients. 2018;10(7):812.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Sujithra K, Srinivasan S, Indumathi D, Vinothkumar V. Allyl methyl sulfide, an organosulfur compound alleviates hyperglycemia mediated hepatic oxidative stress and inflammation in streptozotocin-induced experimental rats. Biomed Pharmacother. 2018;107:292–302.

    Article  PubMed  CAS  Google Scholar 

  4. Selvamuthukumar S, Anandam S, Krishnamoorthy K, Rajappan M. Nanosponges: a novel class of drug delivery system-review. J Pharm Pharm Sci. 2012;15(1):103–11.

    Article  Google Scholar 

  5. Rossi S, Ferrari F, Bonferoni MC, Caramella C. Characterization of chitosan hydrochloride–mucin interaction by means of viscosimetric and turbidimetric measurements. Eur J Pharm Sci. 2000;10(4):251–7.

    Article  PubMed  CAS  Google Scholar 

  6. Kumar S, Trotta F, Rao R. Encapsulation of babchi oil in cyclodextrin-based nanosponges: physicochemical characterization, photodegradation, and in vitro cytotoxicity studies. Pharmaceutics. 2018;10(4):169.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Swaminathan S, Cavalli R, Trotta F. Cyclodextrin-based nanosponges: a versatile platform for cancer nanotherapeutics development. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2016;8(4):579–601.

    PubMed  CAS  Google Scholar 

  8. Trotta F. Cyclodextrin nanosponges and their applications. Cyclodextrins in pharmaceutics, cosmetics, and biomedicine: current and future industrial applications. 2011:323–42.

  9. Shende P, Kulkarni YA, Gaud RS, Deshmukh K, Cavalli R, Trotta F, et al. Acute and repeated dose toxicity studies of different beta-cyclodextrin-based nanosponge formulations. J Pharm Sci. 2015;104(5):1856–63.

    Article  PubMed  CAS  Google Scholar 

  10. Mognetti B, Barberis A, Marino S, Berta G, De Francia S, Trotta F, et al. In vitro enhancement of anti-cancer activity of paclitaxel by a cremophor free cyclodextrin-based nanosponge formulation. J Incl Phenom Macrocycl Chem. 2012;74:201–10.

    Article  CAS  Google Scholar 

  11. Rao M, Bajaj A, Khole I, Munjapara G, Trotta F. In vitro and in vivo evaluation of β-cyclodextrin-based nanosponges of telmisartan. J Incl Phenom Macrocycl Chem. 2013;77:135–45.

    Article  CAS  Google Scholar 

  12. Soloway S, Wilen SH. Improved ferric chloride test for phenols. Anal Chem. 1952;24(6):979–83.

    Article  CAS  Google Scholar 

  13. Rao MR, Shirsath C. Enhancement of bioavailability of non-nucleoside reverse transciptase inhibitor using nanosponges. AAPS PharmSciTech. 2017;18(5):1728–38.

    Article  PubMed  CAS  Google Scholar 

  14. Swaminathan S, Vavia P, Trotta F, Torne S. Formulation of betacyclodextrin based nanosponges of itraconazole. J Incl Phenom Macrocycl Chem. 2007;57(1):89–94.

    Article  CAS  Google Scholar 

  15. Pushpalatha R, Selvamuthukumar S, Kilimozhi D. Cross-linked, cyclodextrin-based nanosponges for curcumin delivery-Physicochemical characterization, drug release, stability and cytotoxicity. Journal of drug delivery science and technology. 2018;45:45–53.

    Article  CAS  Google Scholar 

  16. König WA, Joulain D, Hochmuth D. Terpenoids and related constituents of essential oils. Library of MassFinder. 2004;2.

  17. Sharma D, Maheshwari D, Philip G, Rana R, Bhatia S, Singh M, et al. Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: in vitro and in vivo evaluation. BioMed research international. 2014;2014.

  18. Prieto P, Pineda M, Aguilar M. Spectrophotometric quantitation of anti-oxidant capacity through the formation of a phosphomolybdenum complex: specific application to the determination of vitamin E. Anal Biochem. 1999;269(2):337–41.

    Article  PubMed  CAS  Google Scholar 

  19. Mensor LL, Menezes FS, Leitão GG, Reis AS, Santos TCd, Coube CS, et al. Screening of Brazilian plant extracts for anti-oxidant activity by the use of DPPH free radical method. Phytother Res. 2001;15(2):127–30.

  20. Rastogi S, Iqbal MS, Ohri D. In vitro study of anti-inflammatory and anti-oxidant activity of some medicinal plants and their interrelationship. In Vitro. 2018;11(4):2455–3891.

    Google Scholar 

Download references

Acknowledgements

The authors thank the Rashtriya Uchchatar Shiksha Abhiyan (RUSA 2.0) India for providing financial support in the form of a project fellow to Ms. J. Saranya is gratefully acknowledged. The authors gratefully acknowledge the help of A. Arenganathan, Technical Officer, Department of Pharmacy, Faculty of Engineering, Annamalai University, Annamalai Nagar, Tamilnadu, India, for help with nanoparticle preparation.

Author information

Authors and Affiliations

Authors

Contributions

J. Saranya, V. Vinothkumar, S. Selvamuthukumar, and P. Venkatesan designed the experiments. J. Saranya, S. Selvamuthukumar, P. Venkatesan, D. Geetha, D. Ramachandhiran, and B. Vaitheeswari performed the experiments. J. Saranya, V. Vinothkumar, S. Selvamuthukumar, P. Venkatesan analyzed the data. J. Saranya, V. Vinothkumar, and S. Selvamuthukumar wrote the manuscript.

Corresponding author

Correspondence to Vinothkumar Veerasamy.

Ethics declarations

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jawaharlal, S., Subramanian, S., Palanivel, V. et al. Cross-Linked β-Cyclodextrin Based Nanosponges for Allyl Methyl Sulfide Delivery-Physicochemical Characterization and In Vitro Study. J Pharm Innov 18, 1594–1601 (2023). https://doi.org/10.1007/s12247-023-09741-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12247-023-09741-6

Keywords

Navigation